US Stock MarketDetailed Quotes

URGN UroGen Pharma Ltd

Watchlist
  • 11.350
  • -0.120-1.05%
Close Dec 13 16:00 ET
  • 11.350
  • 0.0000.00%
Post 16:20 ET
478.96MMarket Cap-3.76P/E (TTM)

UroGen Pharma Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
69.30%249.58M
409.67%241.08M
152.17%164.05M
37.02%136.97M
37.02%136.97M
53.70%147.42M
-57.67%47.3M
-52.32%65.05M
12.14%99.96M
12.14%99.96M
-Cash and cash equivalents
4.70%124.92M
992.92%219.97M
259.71%131.44M
71.46%95M
71.46%95M
315.90%119.31M
-75.06%20.13M
-65.33%36.54M
24.91%55.41M
24.91%55.41M
-Short-term investments
343.41%124.66M
-22.33%21.11M
14.35%32.61M
-5.81%41.97M
-5.81%41.97M
-58.18%28.11M
-12.48%27.17M
-8.21%28.51M
-0.50%44.56M
-0.50%44.56M
Receivables
77.49%22.8M
12.32%17.42M
13.33%14.16M
21.56%15.44M
21.56%15.44M
36.25%12.85M
33.72%15.51M
31.52%12.49M
8.42%12.7M
8.42%12.7M
-Accounts receivable
77.49%22.8M
12.32%17.42M
13.33%14.16M
21.56%15.44M
21.56%15.44M
36.25%12.85M
33.72%15.51M
31.52%12.49M
8.42%12.7M
8.42%12.7M
Inventory
51.82%7.59M
49.20%7.44M
32.51%7.24M
31.17%5.67M
31.17%5.67M
2.88%5M
-1.17%4.99M
14.93%5.47M
-10.49%4.33M
-10.49%4.33M
Restricted cash
31.33%1.07M
1.10%825K
1.11%823K
0.98%821K
0.98%821K
0.62%817K
0.62%816K
48.00%814K
-33.69%813K
-33.69%813K
Other current assets
-12.38%14.05M
-4.05%12.21M
-13.63%10.49M
-7.39%10.28M
-7.39%10.28M
51.59%16.04M
21.95%12.72M
30.95%12.15M
48.49%11.1M
48.49%11.1M
Total current assets
62.03%295.1M
242.99%278.97M
105.02%196.76M
31.25%169.19M
31.25%169.19M
49.78%182.12M
-41.75%81.33M
-40.21%95.97M
12.69%128.91M
12.69%128.91M
Non current assets
Net PPE
-39.15%1.66M
-39.34%1.83M
-41.46%2.01M
-37.05%2.36M
-37.05%2.36M
-34.81%2.73M
-18.92%3.02M
26.08%3.43M
19.13%3.75M
19.13%3.75M
-Gross PPE
-9.51%5.87M
-9.36%5.98M
-10.52%6.08M
-8.51%6.31M
-8.51%6.31M
-8.58%6.49M
3.06%6.59M
31.69%6.8M
28.40%6.9M
28.40%6.9M
-Accumulated depreciation
-11.99%-4.21M
-15.94%-4.15M
-21.03%-4.08M
-25.46%-3.95M
-25.46%-3.95M
-29.10%-3.76M
-33.64%-3.58M
-37.94%-3.37M
-41.51%-3.15M
-41.51%-3.15M
Investments and advances
-28.68%4.64M
-97.45%203K
-95.27%481K
--4.5M
--4.5M
--6.51M
1,084.25%7.97M
1,408.16%10.17M
--0
--0
Other non current assets
-76.04%545K
-72.11%848K
-60.87%1.32M
-23.62%2.26M
-23.62%2.26M
-15.55%2.28M
43.24%3.04M
88.52%3.38M
93.16%2.96M
93.16%2.96M
Total non current assets
-40.52%6.85M
-79.46%2.88M
-77.54%3.81M
35.95%9.13M
35.95%9.13M
67.32%11.51M
115.25%14.03M
227.12%16.98M
25.32%6.71M
25.32%6.71M
Total assets
55.94%301.94M
195.56%281.85M
77.57%200.57M
31.48%178.31M
31.48%178.31M
50.72%193.63M
-34.75%95.36M
-31.84%112.95M
13.26%135.62M
13.26%135.62M
Liabilities
Current liabilities
Payables
37.49%5.56M
78.51%8.32M
-10.18%6.26M
17.86%6.51M
17.86%6.51M
58.78%4.04M
89.62%4.66M
64.57%6.97M
-4.48%5.53M
-4.48%5.53M
-accounts payable
37.49%5.56M
78.51%8.32M
-10.18%6.26M
17.86%6.51M
17.86%6.51M
58.78%4.04M
89.62%4.66M
64.57%6.97M
-4.48%5.53M
-4.48%5.53M
Current accrued expenses
40.70%14.13M
31.45%15.44M
17.09%11.9M
46.21%10.02M
46.21%10.02M
47.44%10.04M
89.73%11.74M
78.22%10.16M
8.55%6.86M
8.55%6.86M
Other current liabilities
14.64%4.07M
-0.58%3.62M
0.38%3.2M
17.83%3.86M
17.83%3.86M
17.73%3.55M
22.80%3.64M
-20.55%3.19M
-1.62%3.28M
-1.62%3.28M
Current liabilities
27.14%32.79M
27.86%34.22M
4.38%26.34M
30.51%31.21M
30.51%31.21M
35.73%25.79M
48.36%26.77M
32.18%25.23M
6.86%23.92M
6.86%23.92M
Non current liabilities
Long term debt and capital lease obligation
22.48%121.92M
-1.27%98.24M
-1.12%98.23M
0.27%99.4M
0.27%99.4M
35.02%99.54M
36.85%99.51M
39.78%99.34M
24,805.28%99.12M
24,805.28%99.12M
-Long term debt
23.54%121.71M
-0.49%97.81M
-0.36%97.59M
1.04%98.55M
1.04%98.55M
37.08%98.52M
38.06%98.3M
38.34%97.94M
--97.54M
--97.54M
-Long term capital lease obligation
-79.34%212K
-64.85%425K
-54.60%637K
-46.78%844K
-46.78%844K
-44.72%1.03M
-20.20%1.21M
406.50%1.4M
298.49%1.59M
298.49%1.59M
Derivative product liabilities
10.49%118.53M
10.88%115.88M
10.83%112.95M
10.92%109.72M
10.92%109.72M
11.52%107.28M
11.82%104.51M
13.51%101.91M
15.41%98.92M
15.41%98.92M
Total non current liabilities
16.11%243.64M
4.97%217.31M
4.94%214.37M
5.59%212.31M
5.59%212.31M
21.46%209.84M
22.49%207.03M
24.79%204.27M
126.03%201.06M
126.03%201.06M
Total liabilities
17.32%276.43M
7.59%251.54M
4.88%240.71M
8.24%243.52M
8.24%243.52M
22.88%235.63M
24.99%233.8M
25.56%229.51M
102.08%224.98M
102.08%224.98M
Shareholders'equity
Share capital
36.90%115K
75.00%112K
54.69%99K
41.27%89K
41.27%89K
33.33%84K
3.23%64K
3.23%64K
3.28%63K
3.28%63K
-common stock
36.90%115K
75.00%112K
54.69%99K
41.27%89K
41.27%89K
33.33%84K
3.23%64K
3.23%64K
3.28%63K
3.28%63K
Retained earnings
-17.66%-768.71M
-17.99%-745.04M
-17.18%-711.63M
-17.72%-679.35M
-17.72%-679.35M
-19.17%-653.33M
-20.87%-631.45M
-22.51%-607.32M
-23.49%-577.1M
-23.49%-577.1M
Paid-in capital
29.85%793.87M
57.22%775.27M
36.82%671.44M
25.88%614.04M
25.88%614.04M
26.05%611.39M
2.41%493.11M
2.53%490.74M
2.54%487.79M
2.54%487.79M
Gains losses not affecting retained earnings
276.12%236K
79.87%-31K
17.78%-37K
111.21%12K
111.21%12K
13.55%-134K
-175.00%-154K
34.78%-45K
-328.00%-107K
-328.00%-107K
Total stockholders'equity
160.76%25.52M
121.90%30.31M
65.57%-40.13M
27.02%-65.21M
27.02%-65.21M
33.65%-41.99M
-238.36%-138.43M
-582.64%-116.55M
-1,162.18%-89.36M
-1,162.18%-89.36M
Total equity
160.76%25.52M
121.90%30.31M
65.57%-40.13M
27.02%-65.21M
27.02%-65.21M
33.65%-41.99M
-238.36%-138.43M
-582.64%-116.55M
-1,162.18%-89.36M
-1,162.18%-89.36M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 69.30%249.58M409.67%241.08M152.17%164.05M37.02%136.97M37.02%136.97M53.70%147.42M-57.67%47.3M-52.32%65.05M12.14%99.96M12.14%99.96M
-Cash and cash equivalents 4.70%124.92M992.92%219.97M259.71%131.44M71.46%95M71.46%95M315.90%119.31M-75.06%20.13M-65.33%36.54M24.91%55.41M24.91%55.41M
-Short-term investments 343.41%124.66M-22.33%21.11M14.35%32.61M-5.81%41.97M-5.81%41.97M-58.18%28.11M-12.48%27.17M-8.21%28.51M-0.50%44.56M-0.50%44.56M
Receivables 77.49%22.8M12.32%17.42M13.33%14.16M21.56%15.44M21.56%15.44M36.25%12.85M33.72%15.51M31.52%12.49M8.42%12.7M8.42%12.7M
-Accounts receivable 77.49%22.8M12.32%17.42M13.33%14.16M21.56%15.44M21.56%15.44M36.25%12.85M33.72%15.51M31.52%12.49M8.42%12.7M8.42%12.7M
Inventory 51.82%7.59M49.20%7.44M32.51%7.24M31.17%5.67M31.17%5.67M2.88%5M-1.17%4.99M14.93%5.47M-10.49%4.33M-10.49%4.33M
Restricted cash 31.33%1.07M1.10%825K1.11%823K0.98%821K0.98%821K0.62%817K0.62%816K48.00%814K-33.69%813K-33.69%813K
Other current assets -12.38%14.05M-4.05%12.21M-13.63%10.49M-7.39%10.28M-7.39%10.28M51.59%16.04M21.95%12.72M30.95%12.15M48.49%11.1M48.49%11.1M
Total current assets 62.03%295.1M242.99%278.97M105.02%196.76M31.25%169.19M31.25%169.19M49.78%182.12M-41.75%81.33M-40.21%95.97M12.69%128.91M12.69%128.91M
Non current assets
Net PPE -39.15%1.66M-39.34%1.83M-41.46%2.01M-37.05%2.36M-37.05%2.36M-34.81%2.73M-18.92%3.02M26.08%3.43M19.13%3.75M19.13%3.75M
-Gross PPE -9.51%5.87M-9.36%5.98M-10.52%6.08M-8.51%6.31M-8.51%6.31M-8.58%6.49M3.06%6.59M31.69%6.8M28.40%6.9M28.40%6.9M
-Accumulated depreciation -11.99%-4.21M-15.94%-4.15M-21.03%-4.08M-25.46%-3.95M-25.46%-3.95M-29.10%-3.76M-33.64%-3.58M-37.94%-3.37M-41.51%-3.15M-41.51%-3.15M
Investments and advances -28.68%4.64M-97.45%203K-95.27%481K--4.5M--4.5M--6.51M1,084.25%7.97M1,408.16%10.17M--0--0
Other non current assets -76.04%545K-72.11%848K-60.87%1.32M-23.62%2.26M-23.62%2.26M-15.55%2.28M43.24%3.04M88.52%3.38M93.16%2.96M93.16%2.96M
Total non current assets -40.52%6.85M-79.46%2.88M-77.54%3.81M35.95%9.13M35.95%9.13M67.32%11.51M115.25%14.03M227.12%16.98M25.32%6.71M25.32%6.71M
Total assets 55.94%301.94M195.56%281.85M77.57%200.57M31.48%178.31M31.48%178.31M50.72%193.63M-34.75%95.36M-31.84%112.95M13.26%135.62M13.26%135.62M
Liabilities
Current liabilities
Payables 37.49%5.56M78.51%8.32M-10.18%6.26M17.86%6.51M17.86%6.51M58.78%4.04M89.62%4.66M64.57%6.97M-4.48%5.53M-4.48%5.53M
-accounts payable 37.49%5.56M78.51%8.32M-10.18%6.26M17.86%6.51M17.86%6.51M58.78%4.04M89.62%4.66M64.57%6.97M-4.48%5.53M-4.48%5.53M
Current accrued expenses 40.70%14.13M31.45%15.44M17.09%11.9M46.21%10.02M46.21%10.02M47.44%10.04M89.73%11.74M78.22%10.16M8.55%6.86M8.55%6.86M
Other current liabilities 14.64%4.07M-0.58%3.62M0.38%3.2M17.83%3.86M17.83%3.86M17.73%3.55M22.80%3.64M-20.55%3.19M-1.62%3.28M-1.62%3.28M
Current liabilities 27.14%32.79M27.86%34.22M4.38%26.34M30.51%31.21M30.51%31.21M35.73%25.79M48.36%26.77M32.18%25.23M6.86%23.92M6.86%23.92M
Non current liabilities
Long term debt and capital lease obligation 22.48%121.92M-1.27%98.24M-1.12%98.23M0.27%99.4M0.27%99.4M35.02%99.54M36.85%99.51M39.78%99.34M24,805.28%99.12M24,805.28%99.12M
-Long term debt 23.54%121.71M-0.49%97.81M-0.36%97.59M1.04%98.55M1.04%98.55M37.08%98.52M38.06%98.3M38.34%97.94M--97.54M--97.54M
-Long term capital lease obligation -79.34%212K-64.85%425K-54.60%637K-46.78%844K-46.78%844K-44.72%1.03M-20.20%1.21M406.50%1.4M298.49%1.59M298.49%1.59M
Derivative product liabilities 10.49%118.53M10.88%115.88M10.83%112.95M10.92%109.72M10.92%109.72M11.52%107.28M11.82%104.51M13.51%101.91M15.41%98.92M15.41%98.92M
Total non current liabilities 16.11%243.64M4.97%217.31M4.94%214.37M5.59%212.31M5.59%212.31M21.46%209.84M22.49%207.03M24.79%204.27M126.03%201.06M126.03%201.06M
Total liabilities 17.32%276.43M7.59%251.54M4.88%240.71M8.24%243.52M8.24%243.52M22.88%235.63M24.99%233.8M25.56%229.51M102.08%224.98M102.08%224.98M
Shareholders'equity
Share capital 36.90%115K75.00%112K54.69%99K41.27%89K41.27%89K33.33%84K3.23%64K3.23%64K3.28%63K3.28%63K
-common stock 36.90%115K75.00%112K54.69%99K41.27%89K41.27%89K33.33%84K3.23%64K3.23%64K3.28%63K3.28%63K
Retained earnings -17.66%-768.71M-17.99%-745.04M-17.18%-711.63M-17.72%-679.35M-17.72%-679.35M-19.17%-653.33M-20.87%-631.45M-22.51%-607.32M-23.49%-577.1M-23.49%-577.1M
Paid-in capital 29.85%793.87M57.22%775.27M36.82%671.44M25.88%614.04M25.88%614.04M26.05%611.39M2.41%493.11M2.53%490.74M2.54%487.79M2.54%487.79M
Gains losses not affecting retained earnings 276.12%236K79.87%-31K17.78%-37K111.21%12K111.21%12K13.55%-134K-175.00%-154K34.78%-45K-328.00%-107K-328.00%-107K
Total stockholders'equity 160.76%25.52M121.90%30.31M65.57%-40.13M27.02%-65.21M27.02%-65.21M33.65%-41.99M-238.36%-138.43M-582.64%-116.55M-1,162.18%-89.36M-1,162.18%-89.36M
Total equity 160.76%25.52M121.90%30.31M65.57%-40.13M27.02%-65.21M27.02%-65.21M33.65%-41.99M-238.36%-138.43M-582.64%-116.55M-1,162.18%-89.36M-1,162.18%-89.36M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data